Stephen A Berry1, Kelly A Gebo, Richard M Rutstein, Keri N Althoff, P Todd Korthuis, Aditya H Gaur, Stephen A Spector, Robert Warford, Baligh R Yehia, Allison L Agwu. 1. From the Departments of *Medicine and †Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD; ‡Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; §Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ¶Department of Medicine, Oregon Health and Science University, Portland, OR; ‖Department of Pediatrics, St Jude's Children's Hospital, Memphis, TN; **Department of Pediatrics, University of California, San Diego, CA; ††Department of Medicine, St. Lukes-Roosevelt Hospital Center, New York, NY; and ‡‡Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Abstract
BACKGROUND: Contemporary trends in hospitalization patterns among perinatally HIV-infected (PHIV) patients are unknown. We describe rates and reasons for hospitalizations stratified by age group during 2003-2010 within a large cohort of PHIV patients. METHODS: 579 PHIV patients engaged in care at 6 geographically diverse pediatric HIV centers affiliated through the HIV Research Network were included. Modified Clinical Classification Software assigned primary ICD-9 codes into diagnostic categories. Analysis was performed using negative binomial regression with generalized estimating equations. RESULTS: There were 699 all-cause hospitalizations. The overall rate for the full cohort was 19.9/100 person-years, and overall rates for 0-4, 5-16 and 17-24 year-olds were 25.1, 14.7 and 34.2/100 person-years, respectively. Declines were seen in unadjusted all-cause rates for the whole group [incidence rate ratio per year, 0.93 (0.87-0.99)] and for 5-16 [0.87 (0.76-0.99)] and 17-24 year-olds [0.87 (0.80-0.95)]. After adjustment for CD4, HIV-1 RNA and demographics, rates were no longer declining. Non-AIDS-defining infections and AIDS-defining illnesses together caused 349 (50%) admissions. Declines in these categories drove the overall declines in unadjusted rates. No increases over time were seen for cardiovascular, renal or any other diagnostic categories. CONCLUSIONS: While the declines in hospitalizations are reassuring, continued efforts are needed to address the persistently high infectious and non-infectious morbidity among PHIV patients. Innovative strategies may be most critical for 17-24 year-olds. Lack of increases in cardiovascular and renal admissions provides modest, preliminary reassurance against severe non-infectious complications from longstanding HIV infection and antiretroviral exposure.
BACKGROUND: Contemporary trends in hospitalization patterns among perinatally HIV-infected (PHIV) patients are unknown. We describe rates and reasons for hospitalizations stratified by age group during 2003-2010 within a large cohort of PHIV patients. METHODS: 579 PHIV patients engaged in care at 6 geographically diverse pediatric HIV centers affiliated through the HIV Research Network were included. Modified Clinical Classification Software assigned primary ICD-9 codes into diagnostic categories. Analysis was performed using negative binomial regression with generalized estimating equations. RESULTS: There were 699 all-cause hospitalizations. The overall rate for the full cohort was 19.9/100 person-years, and overall rates for 0-4, 5-16 and 17-24 year-olds were 25.1, 14.7 and 34.2/100 person-years, respectively. Declines were seen in unadjusted all-cause rates for the whole group [incidence rate ratio per year, 0.93 (0.87-0.99)] and for 5-16 [0.87 (0.76-0.99)] and 17-24 year-olds [0.87 (0.80-0.95)]. After adjustment for CD4, HIV-1 RNA and demographics, rates were no longer declining. Non-AIDS-defining infections and AIDS-defining illnesses together caused 349 (50%) admissions. Declines in these categories drove the overall declines in unadjusted rates. No increases over time were seen for cardiovascular, renal or any other diagnostic categories. CONCLUSIONS: While the declines in hospitalizations are reassuring, continued efforts are needed to address the persistently high infectious and non-infectious morbidity among PHIV patients. Innovative strategies may be most critical for 17-24 year-olds. Lack of increases in cardiovascular and renal admissions provides modest, preliminary reassurance against severe non-infectious complications from longstanding HIV infection and antiretroviral exposure.
Authors: C Dollfus; J Le Chenadec; A Faye; S Blanche; N Briand; C Rouzioux; J Warszawski Journal: Clin Infect Dis Date: 2010-07-15 Impact factor: 9.079
Authors: Salvador Resino; Rosa Resino; José Maria Bellón; Dariela Micheloud; Maria Dolores Gurbindo Gutiérrez; Maria Isabel de José; José Tomás Ramos; Pablo Martín Fontelos; Luis Ciria; Maria Angeles Muñoz-Fernández Journal: Clin Infect Dis Date: 2006-06-09 Impact factor: 9.079
Authors: Ali Judd; Katherine L Boyd; Wolfgang Stöhr; David Dunn; Karina Butler; Hermione Lyall; Mike Sharland; Delane Shingadia; Andrew Riordan; Di M Gibb Journal: AIDS Date: 2010-02-20 Impact factor: 4.177
Authors: Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks Journal: AIDS Date: 2008-07-11 Impact factor: 4.177
Authors: Caroline Foster; Ali Judd; Pat Tookey; Gareth Tudor-Williams; David Dunn; Delane Shingadia; Karina Butler; Mike Sharland; Di Gibb; Hermione Lyall Journal: AIDS Patient Care STDS Date: 2009-03 Impact factor: 5.078
Authors: Ali Judd; Katja Doerholt; Pat A Tookey; Mike Sharland; Andrew Riordan; Esse Menson; Vas Novelli; E G Hermione Lyall; Janet Masters; Gareth Tudor-Williams; Trinh Duong; Di M Gibb Journal: Clin Infect Dis Date: 2007-08-27 Impact factor: 9.079
Authors: Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello Journal: JAMA Pediatr Date: 2017-05-01 Impact factor: 16.193
Authors: Anne M Neilan; Frances Lu; Kelly A Gebo; Rebeca Diaz-Reyes; Mingshu Huang; Robert A Parker; Brad Karalius; Kunjal Patel; Cindy Voss; Andrea L Ciaranello; Allison L Agwu Journal: J Acquir Immune Defic Syndr Date: 2020-04-01 Impact factor: 3.771